Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones de la editorial INT MEDICAL PRESS LTD

Tipo Año Título Fuente
Artículo2017Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trialANTIVIRAL THERAPY
Artículo2015Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfectionANTIVIRAL THERAPY
Artículo2014Darunavir minimum plasma concentration and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patientsANTIVIRAL THERAPY
Artículo2014Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapyANTIVIRAL THERAPY
Resumen congreso2013HIV drug resistance occurring during low-level viraemia is associated with subsequent virological failureANTIVIRAL THERAPY
Artículo2013Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008-2010ANTIVIRAL THERAPY
Artículo2012Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health careANTIVIRAL THERAPY
Artículo2012Prognosis of 2009 A(H1N1) influenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapyANTIVIRAL THERAPY
Artículo2011HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in SpainANTIVIRAL THERAPY
Artículo2011Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipientsANTIVIRAL THERAPY
Artículo2010Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal modelANTIVIRAL THERAPY
Artículo2010Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosineANTIVIRAL THERAPY
Artículo2009Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammationANTIVIRAL THERAPY
Artículo2009Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infectionANTIVIRAL THERAPY
Artículo2008Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcomeANTIVIRAL THERAPY
Artículo2008Antiretroviral-associated portal hypertension: A new clinical condition? Prevalence, predictors and outcomeANTIVIRAL THERAPY
Artículo2008Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavirANTIVIRAL THERAPY
Artículo2007Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patientsANTIVIRAL THERAPY
Artículo2007Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patientsANTIVIRAL THERAPY
Artículo2006Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis CANTIVIRAL THERAPY
Artículo2006Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapyANTIVIRAL THERAPY
Artículo2004Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatmentANTIVIRAL THERAPY
Artículo2003Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAARTANTIVIRAL THERAPY
Artículo2003Highly active antiretroviral therapy: Physician experience and enhanced adherence to prescription refillANTIVIRAL THERAPY
Artículo2003Study of different systems for interpreting results of genotypic antiretroviral drug resistance testsANTIVIRAL THERAPY
Artículo2002Baseline thymic volume is a predictor for CD4 T cell repopulation in adult HIV-infected patients under highly active antiretroviral therapyANTIVIRAL THERAPY
Artículo2002Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failureANTIVIRAL THERAPY
Artículo1999Efficiency of drug resistance genotypic tests in specimens with low HIV viral loadANTIVIRAL THERAPY
Artículo1999Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimensANTIVIRAL THERAPY
Artículo1999Presence of genotypic resistance in nucleoside analogue-treated HIV-1-infected patients with undetectable viral loadANTIVIRAL THERAPY
Artículo1997Viraemia and p24 antigenaemia are independent risk factors for the emergence of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infectionANTIVIRAL THERAPY